Clarity Pharmaceuticals Ltd (CU6) - Total Liabilities

Latest as of June 2025: AU$10.94 Million AUD ≈ $7.74 Million USD

Based on the latest financial reports, Clarity Pharmaceuticals Ltd (CU6) has total liabilities worth AU$10.94 Million AUD (≈ $7.74 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Clarity Pharmaceuticals Ltd (CU6) cash flow conversion to assess how effectively this company generates cash.

Clarity Pharmaceuticals Ltd - Total Liabilities Trend (2018–2025)

This chart illustrates how Clarity Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. Check CU6 financial resilience to evaluate the company's liquid asset resilience ratio.

Clarity Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Clarity Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Dongguan Golden Sun Abrasives Co Ltd SHE:300606	China	CN¥535.59 Million
Hefei Department Store Group Co Ltd SHE:000417	China	CN¥6.62 Billion
Suntront Tech SHE:300259	China	CN¥502.55 Million
Jiangsu Canlon Building Materials Co Ltd SHE:300715	China	CN¥3.76 Billion
Puyang Refractories Group Co Ltd SHE:002225	China	CN¥4.74 Billion
AVALON TECHNOLOGIES LTD NSE:AVALON	India	Rs4.54 Billion
Yunnan Yunwei Co Ltd Class A SHG:600725	China	CN¥65.19 Million

Liability Composition Analysis (2018–2025)

This chart breaks down Clarity Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Clarity Pharmaceuticals Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	9.69	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	2.83	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Clarity Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Clarity Pharmaceuticals Ltd (2018–2025)

The table below shows the annual total liabilities of Clarity Pharmaceuticals Ltd from 2018 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$10.94 Million ≈ $7.74 Million	+31.32%
2024-06-30	AU$8.33 Million ≈ $5.90 Million	+7.91%
2023-06-30	AU$7.72 Million ≈ $5.46 Million	+1.78%
2022-06-30	AU$7.59 Million ≈ $5.37 Million	+224.81%
2021-06-30	AU$2.34 Million ≈ $1.65 Million	+144.26%
2020-06-30	AU$956.09K ≈ $676.50K	-15.87%
2019-06-30	AU$1.14 Million ≈ $804.07K	+32.59%
2018-06-30	AU$857.04K ≈ $606.41K	--

About Clarity Pharmaceuticals Ltd

AU:CU6 Australia Biotechnology

Market Cap

$763.38 Million

AU$1.08 Billion AUD

Market Cap Rank

#10389 Global

#258 in Australia

Share Price

AU$2.90

Change (1 day)

+2.47%

52-Week Range

AU$1.90 - AU$5.70

All Time High

AU$8.79